Novavax Inc (NVAX) stock
NVAXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 4/30
$7.96+0.00 (0.00%)
Close on Nov 18, 2026Market cap $1.31BP/E –Yield –
Novavax price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Novavax's price to book ratio was 36.2× on Oct 31, 2025, against 12.8× a year earlier. Over the last 5 years it ranged from 3.5× to 130.6×, with a median of 8.6×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2025 | Oct 31, 2025 | 36.2× | −29.0 |
| 2022 | Jul 29, 2022 | 65.2× | +41.8 |
| 2021 | Dec 31, 2021 | 23.4× | −42.5 |
| 2020 | Dec 31, 2020 | 65.9× | +58.8 |
| 2017 | Jan 31, 2017 | 7.1× | +0.3 |
| 2016 | Dec 30, 2016 | 6.9× | +0.7 |
| 2015 | Dec 31, 2015 | 6.2× | +0.8 |
| 2014 | Dec 31, 2014 | 5.4× | +0.5 |
| 2013 | Dec 31, 2013 | 4.9× | +0.8 |
| 2012 | Dec 31, 2012 | 4.1× | +1.4 |
| 2011 | Dec 30, 2011 | 2.7× | – |
See a number that looks wrong?